Bryan Bedford disclosed purchase in Regeneron Pharmaceuticals
Bryan Bedford reported a purchase transaction in Regeneron Pharmaceuticals (REGN) on 2025-07-10.
Signal
Congress Trade
Action
Buy
Capital
Disclosure amount unavailable
Why it matters
Congress disclosures can highlight policy-adjacent trading activity. This card is generated from canonical action facts, not request-time scraping.